Pleuropericarditis can occur as an extraintestinal complication of inflammatory bowel disease even during quiescent phases, and typically responds to NSAIDs or corticosteroids.
May support NSAID or corticosteroid use for IBD pleuropericarditis; leaves open confirmation in prospective cohorts.
We report three cases of pleuropericarditis complicating the clinical course of inflammatory bowel disease. This extraintestinal complication developed in all three patients during the quiescent phase of the disease. One patient had ulcerative colitis, while two patients had Crohn's disease. Aspirin and/or indomethacin were effective in treating two of the three patients, and the third patient required prednisone in addition. Chest symptoms in patients with inflammatory bowel disease should be evaluated to exclude myopericardial-pleural disease.
No takes yet. Share an insight, caveat, or question.
Rashmi Patwardhan (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: